Pathogenesis of bullous pemphigoid.

Area of Science:

• Immunodermatology
• Autoimmunity
• Molecular Biology

Background:

• Bullous pemphigoid (BP) is the most common autoimmune blistering disease.
• BP pathogenesis involves autoantibodies against type XVII collagen (COL17A1).
• Understanding immune responses in BP is crucial for developing targeted therapies.

Purpose of the Study:

• To elucidate the pathogenic mechanisms of autoantibodies against COL17A1 in bullous pemphigoid.
• To investigate the role of immune cell infiltration and activation in BP.
• To explore the contribution of autoreactive T lymphocytes to autoantibody production.

Main Methods:

• Passive transfer of IgG and IgE autoantibodies against COL17A1 into animal models.
• In vitro studies analyzing ectodomain shedding of COL17A1.
• Analysis of immune cell responses, including complement activation, mast cell degranulation, and neutrophil/eosinophil infiltration.

Main Results:

• Passive transfer of anti-COL17A1 antibodies confirmed their pathogenicity.
• Demonstrated subsequent immune responses: complement activation, mast cell degranulation, and inflammatory cell infiltration.
• In vitro studies provided insights into COL17A1 shedding mechanisms.
• Highlighted the pathogenic role of CD4+ T lymphocytes in autoantibody development.

Conclusions:

• Autoantibodies against type XVII collagen are key drivers of bullous pemphigoid.
• Immune responses, including inflammation and complement activation, are critical in BP.
• Autoreactive CD4+ T cells play a significant role in the development of pathogenic autoantibodies.
• Further research into these pathways can inform novel therapeutic strategies for bullous pemphigoid.